Clinical Trial: Early Feasibility Study of 3830 Lead Implantation Via the Middle Cardiac Vein in Patients With Prior or Planned Tricuspid Valve Intervention

U.S., Sept. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07805525) titled 'Early Feasibility Study of 3830 Lead Implantation Via the Middle Cardiac Vein in Patients With Prior or Planned Tricuspid Valve Intervention' on Aug. 27.

Brief Summary: Prospective, single center, early feasibility study designed to evaluate the initial safety and device performance of the Medtronic 3830 Lead when implanted via the Middle Cardiac Vein in patients with prior or planned tricuspid valve interventions.

Study Start Date: Nov., 2026

Study Type: INTERVENTIONAL

Condition: Cardiac Conduction Disorders Requiring Permanent Pacing in Patients With Prior or Planned Tricuspid Valve Intervention

Intervention: DEVICE: Pacemak...